Takuya Mayumi Selected Research

Takuya Mayumi Research Topics

4	Septic Shock (Toxic Shock Syndrome) 08/2021 - 01/2021
4	Sepsis (Septicemia) 08/2021 - 01/2021
3	COVID-19 12/2022 - 01/2021
3	Respiratory Insufficiency (Respiratory Failure) 07/2022 - 01/2021
2	Bacterial Pneumonia 07/2022 - 07/2022
1	Arteriovenous Fistula 01/2021
1	Hematoma 04/2015
1	Coronary Occlusion 04/2015

4	Oxygen (Dioxygen)IBA 07/2022 - 01/2021
3	AnticoagulantsIBA 12/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2021
2	SteroidsIBA 07/2022 - 07/2022
2	ProcalcitoninIBA 07/2022 - 07/2022
2	C-Reactive ProteinIBA 07/2022 - 07/2022
2	favipiravirIBA 01/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2021
2	remdesivirIBA 01/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2021
1	baricitinibIBA 01/2021
1	casirivimab and imdevimab drug combinationIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021

4	Artificial Respiration (Mechanical Ventilation) 07/2022 - 01/2021
4	Critical Care (Surgical Intensive Care) 08/2021 - 01/2021
3	Therapeutics 07/2022 - 01/2021
2	Respiratory Therapy (Therapy, Respiratory) 07/2022 - 07/2022
2	Extracorporeal Membrane Oxygenation 07/2022 - 07/2022
2	Cannula 07/2022 - 07/2022
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 07/2022 - 07/2022
1	Mechanical Ventilators (Ventilator) 01/2021
1	Catheters 04/2015